Washington, D.C. partner Bob Stoll was quoted in a recent International Business Times article, titled, “The US Government Wants To Patent The Ebola Virus, Here’s Why That’s A Good Thing.” The article discussed how a patent on the virus could accelerate the pace of research into an Ebola vaccine by using taxpayer funds for basic research. The U.S. government often seeks patents on viruses and their genetic material in an effort to research the diseases safely. If awarded a patent, the agency would make the material available for public use, which private companies aren’t as likely to do.
“If a company patents it, they could limit access. [The government] could donate it to the public,” Bob said.
Click the link below to read the full article.